This opportunity is no longer accepting applications.
grant PAR-22-256

Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required)

The National Cancer Institute is offering funding to advance cancer-related interventions aimed at improving health equity and reflecting the diverse population of the U.S. The research should test the impact of these interventions on cancer outcomes using pragmatic trials. The funding follows a two-phase approach: the UG3 phase focuses on refining the intervention and preparing for the trial,…

Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) intends to accelerate the development of evidence-based cancer-related interventions to improve health equity and reflect the diversity of people, places, contexts, and settings in the United States. Specifi…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Cancer Institute
Program: SBIR

Dates

Opportunity Released: November 23, 2022
Open for Submission: November 23, 2022
Submission Deadline: November 17, 2025
Application Window Closes: November 17, 2025

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.